Clinical Trial Update: Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

View source ↗

Summary

A completed clinical trial evaluating factors associated with early discontinuation of Betaferon injections in people with multiple sclerosis. The study was spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED